110 related articles for article (PubMed ID: 10073372)
1. Mental health care from the public perspective: the Texas Medication Algorithm Project.
Shon SP; Crismon ML; Toprac MG; Trivedi M; Miller AL; Suppes T; Rush AJ
J Clin Psychiatry; 1999; 60 Suppl 3():16-20; discussion 21. PubMed ID: 10073372
[TBL] [Abstract][Full Text] [Related]
2. Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder.
Suppes T; Swann AC; Dennehy EB; Habermacher ED; Mason M; Crismon ML; Toprac MG; Rush AJ; Shon SP; Altshuler KZ
J Clin Psychiatry; 2001 Jun; 62(6):439-47. PubMed ID: 11465521
[TBL] [Abstract][Full Text] [Related]
3. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.
Crismon ML; Trivedi M; Pigott TA; Rush AJ; Hirschfeld RM; Kahn DA; DeBattista C; Nelson JC; Nierenberg AA; Sackeim HA; Thase ME
J Clin Psychiatry; 1999 Mar; 60(3):142-56. PubMed ID: 10192589
[TBL] [Abstract][Full Text] [Related]
4. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
Trivedi MH; Rush AJ; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Key T; Biggs MM; Shores-Wilson K; Witte B; Suppes T; Miller AL; Altshuler KZ; Shon SP
Arch Gen Psychiatry; 2004 Jul; 61(7):669-80. PubMed ID: 15237079
[TBL] [Abstract][Full Text] [Related]
5. An empirical analysis of cost outcomes of the Texas Medication Algorithm Project.
Kashner TM; Rush AJ; Crismon ML; Toprac M; Carmody TJ; Miller AL; Trivedi MH; Wicker A; Suppes T
Psychiatr Serv; 2006 May; 57(5):648-59. PubMed ID: 16675759
[TBL] [Abstract][Full Text] [Related]
6. Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms.
Gilbert DA; Altshuler KZ; Rago WV; Shon SP; Crismon ML; Toprac MG; Rush AJ
J Clin Psychiatry; 1998 Jul; 59(7):345-51. PubMed ID: 9714262
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
8. Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.
Rush AJ; Crismon ML; Kashner TM; Toprac MG; Carmody TJ; Trivedi MH; Suppes T; Miller AL; Biggs MM; Shores-Wilson K; Witte BP; Shon SP; Rago WV; Altshuler KZ;
J Clin Psychiatry; 2003 Apr; 64(4):357-69. PubMed ID: 12716235
[TBL] [Abstract][Full Text] [Related]
9. Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.
Rush AJ; Rago WV; Crismon ML; Toprac MG; Shon SP; Suppes T; Miller AL; Trivedi MH; Swann AC; Biggs MM; Shores-Wilson K; Kashner TM; Pigott T; Chiles JA; Gilbert DA; Altshuler KZ
J Clin Psychiatry; 1999 May; 60(5):284-91. PubMed ID: 10362434
[TBL] [Abstract][Full Text] [Related]
10. Treatment of schizophrenia: let's talk dollars and sense.
Buckley PF
Am J Manag Care; 1998 Mar; 4(3):369-83. PubMed ID: 10178499
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations.
J Clin Psychiatry; 1998 Jun; 59(6):322-8. PubMed ID: 9671350
[No Abstract] [Full Text] [Related]
12. Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.
Dennehy EB; Suppes T; Rush AJ; Miller AL; Trivedi MH; Crismon ML; Carmody TJ; Kashner TM
Psychol Med; 2005 Dec; 35(12):1695-706. PubMed ID: 16194283
[TBL] [Abstract][Full Text] [Related]
13. Improving mental health treatments through comparative effectiveness research.
Wang PS; Ulbricht CM; Schoenbaum M
Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
[TBL] [Abstract][Full Text] [Related]
14. Algorithms for optimizing the treatment of depression: making the right decision at the right time.
Adli M; Rush AJ; Möller HJ; Bauer M
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S222-9. PubMed ID: 14677083
[TBL] [Abstract][Full Text] [Related]
15. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
Marcus SC; Olfson M
Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
[TBL] [Abstract][Full Text] [Related]
16. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
17. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
Stensland MD; Jacobson JG; Nyhuis A
J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic medication utilization trends among Texas veterans: 1997-2002.
Yang M; Barner JC; Lawson KA; Rascati KL; Wilson JP; Crismon ML; Worchel J; Mascarenas CA
Ann Pharmacother; 2008 Sep; 42(9):1229-38. PubMed ID: 18682544
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
20. A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder.
Pavuluri MN; Henry DB; Devineni B; Carbray JA; Naylor MW; Janicak PG
J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):859-67. PubMed ID: 15213587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
